Skip to main content
SpringerLink
Log in

Control and Prevention of MRSA Infections

  • Protocol
Methicillin-Resistant Staphylococcus aureus (MRSA) Protocols

Part of the book series: Methods in Molecular Biology ((MIMB,volume 391))

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) has posed an immense problem for clinicians in the hospital setting for years, emerging as the most frequent nosocomial infection. To deal with this problem pathogen and others, infectious disease specialists have developed a variety of procedures for their control and prevention, involving options from preventative measures such as decolonization and isolation of MRSA-confirmed patients, to the more simple procedures of hand washing, expanding glove use, and reducing time in the hospital. With the realization that MRSA is now a community problem, there are expanded efforts toward more direct intervention, such as the use of anti-MRSA antibacterials and vaccines, in an attempt to reduce the overall burden of MRSA.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Enright, M. C., Robinson, D. A., Randle, G., Feil, E. J., Grundmann, H., and Spratt, B. G. (2002) The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc. Natl. Acad. Sci. USA 99, 7687–7692.

    Article  CAS  PubMed  Google Scholar 

  2. Solomon, S., Horan, T., Andrus, M., et al. (2003) National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued 2003. Am. J. Infect. Control. 31, 481–498.

    Article  Google Scholar 

  3. Chopra, I. (2003) Antibiotic resistance in Staphylococcus aureus: concerns, causes and cures. Expert Rev. Anti-infect. Ther. 1, 45–55.

    Article  CAS  PubMed  Google Scholar 

  4. Foster, T. J. (2004) The Staphylococcus aureus “superbug”. J. Clin. Invest. 114, 1693–1696.

    CAS  PubMed  Google Scholar 

  5. Barrett, J. F. (2005) MRSA—what is it, and how do we deal with the problem? Expert Opin. Ther. Targets 9, 253–265.

    Article  CAS  PubMed  Google Scholar 

  6. Cooper, B. S., Medley, G. F., Stone, S. P., et al. (2004) Methicillin-resistant Staphylococcus aureus in hospitals and the community: stealth dynamics and control catastrophes. Proc. Natl. Acad. Sci. USA 101, 10,223–10,228.

    Article  CAS  PubMed  Google Scholar 

  7. Boyce, J. M. (2003) Update on resistant Staphylococcus aureus infections. Clin. Updates Infect. Dis. VI, 1–4.

    Google Scholar 

  8. Hiramatsku, K., Cui, L., Kuroda, M., and Ito, T. (2001) The emergence and evolution of methicillin-resistant Staphylococcus aureus. Trends Microbiol. 9, 486–493.

    Article  Google Scholar 

  9. Lindsay, J. A. and Holden, M. T. G. (2004) Staphylococcus aureus: superbug, super genome? Trends Microbiol. 12, 378–385.

    Article  CAS  PubMed  Google Scholar 

  10. Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., and Edmond, M. B. (2004) Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 39, 309–317.

    Article  PubMed  Google Scholar 

  11. Verhoff, J. (2001) Stopping short the spread of methicillin-resistant Staphylococcus aureus. Can. Med. Assoc. J. 165, 31, 32.

    Google Scholar 

  12. Chambers, H. F. (2001) The changing epidemiology of Staphylococcus aureus? Emerg. Infect. Dis. 7, 178–182.

    Article  CAS  PubMed  Google Scholar 

  13. Marshall, C., Kossmann, T., Wesselingh, S., and Spelman, D. (2004) Methicillin-resistant Staphylococcus aureus and beyond: what’s new in the world of the ‘golden staph’? ANZ J. Surg. 74, 465–469.

    Article  PubMed  Google Scholar 

  14. Buckingham, S. C., McDougal, L. K., Cathey, L. D., et al. (2004) Emergence of community-associated methicillin-resistant Staphylococcus aureus at a Memphis, Tennessee Children’s Hospital. Pediatr. Infect. Dis. J. 23, 619–624.

    Article  PubMed  Google Scholar 

  15. Dufour, P., Gillet, Y., Bes, M., et al. (2002) Community-acquired methicillin-resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine leucocidin. Clin. Infect. Dis. 35, 819–824.

    Article  CAS  PubMed  Google Scholar 

  16. Weber, J. T. (2005) Community-associated methicillin-resistant Staphylococcus aureus. Clin. Infect. Dis. 41, S269–S272.

    Article  CAS  PubMed  Google Scholar 

  17. Eady, E. A. and Cove, J. H. (2003) Staphylococcal resistance revisited: community acquired methicillin resistant Staphylococcus aureus—an emerging problem of the management of skin and soft tissue infections. Curr. Opin. Infect. Dis. 16, 103–124.

    CAS  PubMed  Google Scholar 

  18. Melles, D. C., Gorkink, F. J., Boelens, A. M., et al. Natural population dynamics and expansion of pathogenic clones of Staphylococcus aureus. J. Clin. Invest. 114, 1732–1740.

    Google Scholar 

  19. Lee, Y.-L., Cesario, T., Pax, A., Tran, C., Ghouri, A., and Thrupp, L. D. (1999) Nasal colonization by Staphylococcus aureus in active, independent, community seniors. Age Ageing 28, 229–232.

    Article  CAS  PubMed  Google Scholar 

  20. Lucet, J.-C., Chevret, S., Durand-Zaleski, I., Chastang, C., and Regnier, B. (2003) Prevalence and risk factors for carriage of methicillin-resistant Staphylococcus aureus at admission to the intensive care unit. Arch. Intern. Med. 163, 181–188.

    Article  PubMed  Google Scholar 

  21. Kluytmans, J., Van Belkum, A., and Verbrugh, H. (1997) Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin. Microbiol. Rev. 10, 505–520.

    CAS  PubMed  Google Scholar 

  22. Fluit, A. D. and Schmitz, F.-J., eds. (2003) MRSA: Current Perspectives, Csiter Academic Press, Norfolk, UK.

    Google Scholar 

  23. Fey, P. D., Said-Salim, B., Rupp, M. E., et al. (2003) Comparative molecular analysis of community-or hospital-acquired methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 47, 196–203.

    Article  CAS  PubMed  Google Scholar 

  24. Robinson, D. A. and Enright, M. C. (2003) Evolutionary models of the emergence of methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 47(12), 3926–3934.

    Article  CAS  PubMed  Google Scholar 

  25. Robinson, D. A. and Enright, M. C. (2004) Multilocus sequence typing and the evolution of methicillin-resistant Staphylococcus aureus. Clin. Microbiol. Infect. 10, 92–97.

    Article  CAS  PubMed  Google Scholar 

  26. Graffunder, E. M. and Venezia, R. A. (2002) Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials. J. Antimicrob. Chemother. 49, 999–1005.

    Article  CAS  PubMed  Google Scholar 

  27. Crisostomo, M. I., Westh, H., Tomasz, A., Chung, M., Oliveira, D. C., and De Lencastre, H. (2001) The evolution of methicillin resistance in Staphylococcus aureus: similarity of genetic backgrounds in historically early methicillin-susceptible and-resistant isolates and contemporary epidemic clones. PNAS 98, 9965–9870.

    Article  Google Scholar 

  28. Giesbrecht, P., Kersten T., Maidof, H., and Wecke, J. (1998) Staphylococcal cell wall: morphogenesis and fatal variations in the presence of penicillin. Microbiol. Mol. Rev. 62, 1371–1414.

    CAS  Google Scholar 

  29. Pinho, M. G., De Lencastre, H., and Tomasz, A. (2001) An acquired and a native penicillin-binding protein cooperate in building the cell wall of drug-resistant staphylococci. PNAS 98, 10,886–10,891.

    Article  CAS  PubMed  Google Scholar 

  30. Johnson, A. P., Mushtaq, S., Warner, M., and Livermore, D. M. (2004) Activity of daptomycin against multi-resistant Gram-positive bacteria including enterococci and Staphylococcus aureus resistant to linezolid. Int. J. Antimicrob. Agents 24, 315–319.

    Article  CAS  PubMed  Google Scholar 

  31. Anonymous. (2004) Proportion of S. aureus nosocomial infections resistant to oxacillin (MRSA) among intensive care unit patients, 1989–2003. NNIS System. Available at http://www.cdc.gov.lastaccessed2004.

  32. Jones, M. E., Draghi, D. C., Thornsberry, C., Karlowsky, J. A., Sahm, D. C., and Wenzel, R. P. (2004) Emerging resistance among bacterial pathogens in the intensive care unit—a European and North American surveillance study (2000–2002). Ann. Clin. Microbiol. Antimicrob. 3, 14–24.

    Article  PubMed  Google Scholar 

  33. Bouchillon, S. K., Hoban, D. J., Johnson, J. L., et al. (2004) In vitro activity of gemifloxacin and contemporary oral antimicrobial agents against 27,247 Gram-positive and Gram-negative aerobic isolates: a global surveillance study. Int. J. Antimicrob. Agents 23, 181–196.

    Article  CAS  PubMed  Google Scholar 

  34. Speller, D. C. E., Johnson, A. P., James, D., Marples, R. R., Charlett, A., and George, R. C. (1997) Resistance to methicillin and other antibiotics in isolates of Staphylococcus aureus from blood and cerebrospinal fluid, England and Wales, 1989–95. Lancet 350, 323–325.

    Article  CAS  PubMed  Google Scholar 

  35. Reynolds, R., Potz, N., Colman, M., Williams, A., Livermore, D., MacGowan, A., and the BSAC Extended Working Party on Bacteraemia Resistance Surveillance. (2004) J. Antimicrob. Chemother. 53(6), 1018–1032.

    Article  CAS  PubMed  Google Scholar 

  36. Oteo, J., Baquero, F., Vindel, N. A., Campos, J., and the European Antimicrobial Resistance Surveillance System (EARSS) (2004) J. Antimicrob. Chemother. 53(6), 1033–1038.

    Article  CAS  PubMed  Google Scholar 

  37. Farr, B. M. (2004) Prevention and control of methicillin-resistant Staphylococcus aureus infections. Curr. Opin. Infect. Dis. 17, 317–322.

    Article  PubMed  Google Scholar 

  38. Marshall, C., Wesselingh, S., McDonald, M., and Spelman, D. (2004) Control of endemic MRSA—what is the evidence? J. Hosp. Infect. 56, 253–268.

    Article  CAS  PubMed  Google Scholar 

  39. Sheagren, J. N. (1984) Staphylococcus aureus: the persistent pathogen (part 1). N. Engl. J. Med. 310, 1368–1373.

    Article  CAS  PubMed  Google Scholar 

  40. Sheagren, J. N. (1984) Staphylococcus aureus: the persistent pathogen (part 2). N. Engl. J. Med. 310, 1437–1442.

    Article  CAS  PubMed  Google Scholar 

  41. Platt, A. T. (2001) MRSA in intensive care. Nurs. Stand. 15(31), 27–32.

    CAS  PubMed  Google Scholar 

  42. Karchmer, A. W. (2000) Nosocomial bloodstream infections: organisms, risk factors and implications. Clin. Infect. Dis. 31, S139–S143.

    Article  PubMed  Google Scholar 

  43. Bissett, L. (2005) Controlling the risk of MRSA infection: screening and isolating patients. Br. J. Nurs. 14, 386–390.

    PubMed  Google Scholar 

  44. Boyce, J. M., Havill, N. L., Kohan, C., Dumigan, D. G., and Ligi, C. E. (2004) Do infection control measures work for methicillin-resistant Staphylococcus aureus? Infect. Contr. Hosp. Epidemiol. 25, 395–401.

    Article  Google Scholar 

  45. Dettenkofer, M. and Block, C. (2005) Hospital disinfection: efficacy and safety issues. Curr. Opin. Infect. Dis. 18, 320–325.

    Article  PubMed  Google Scholar 

  46. Boyce, J. M., Potter-Bynoe, G., Chenevert, C., and King, T. (1997) Environmental contamination due to methicillin-resistant Staphylococcus aureus: possible infection control implications. Infect. Control Hosp. Epidemiol. 18, 622–627.

    Article  CAS  PubMed  Google Scholar 

  47. Keene, A., Vavagiakis, P., Lee, M. H., et al. (2005) Staphylococcus aureus colonization and the risk of infection in critically ill patients. Infect. Control Hosp. Epidemiol. 26, 622–628.

    Article  PubMed  Google Scholar 

  48. Myatt, R. and Langley, S. (2003) Changes in infection control practice to reduce MRSA infection. Br. J. Nurs. 12, 675–681.

    PubMed  Google Scholar 

  49. Von Eiff, C., Becker, K., Machka, K., Stammer, H., and Peters, G. (2001) Nasal carriage as a source of Staphylococcus aureus bacteria. N. Engl. J. Med. 344, 11–16.

    Article  Google Scholar 

  50. Paterson, D. L. (2004) “Collateral damage“ from cephalosporin or quinolone antibiotic therapy. Clin. Infect. Dis. 15, S341–S345.

    Article  Google Scholar 

  51. Schentag, J. J., Hyatt, J. M., Carr, J. R., et al. (1998) Genesis of methicillin-resistant Staphylococcus aureus (MRSA), how treatment of MRSA infections has selected for vancomycin-resistant Enterococcus faecium, and the importance of antibiotic management and infection control. Clin. Infect. Dis. 26, 1204–1214.

    Article  CAS  PubMed  Google Scholar 

  52. Tenover, F. C. and McDonald, L. C. (2005) Vancomycin-resistant staphylococci and enterococci: epidemiology and control. Curr. Opin. Infect. Dis. 18, 300–305.

    Article  CAS  PubMed  Google Scholar 

  53. Hosein, I. K., Hill, D. W., Jenkins, L. E., and Magee, J. T. (2002) Clinical significance of the emergence of bacterial resistance in the hospital environment. Symp. Ser. Soc. Appl. Microbiol. 31, 90S–97S.

    PubMed  Google Scholar 

  54. Courvalin, P. and Trieu-Cuot, P. (2001) Minimizing potential resistance: the molecular view. Clin. Infect. Dis. 33, S138–S146.

    Article  CAS  PubMed  Google Scholar 

  55. Drlica, K. and Zhao, X. L. (2004) Is ‘dosing-to-cure’ appropriate in the face of antimicrobial resistance? Rev. Med. Microbiol. 15, 73–80.

    Google Scholar 

  56. Blondeau, J. M., Hansen, G., Metzler, K., and Hedlin, P. (2004) The role of PK/PD parameters to avoid selection and increase of resistance: mutant prevention concentration. J. Chemother. 16(3), 1–19.

    CAS  PubMed  Google Scholar 

  57. Bryskier, A. (2005) Anti-MRSA agents: under investigation, in the exploratory phase and clinically available. Expert Rev. Anti. Infect. Ther. 3, 505–553.

    Article  CAS  PubMed  Google Scholar 

  58. Walsh, C. (2003) Where will new antibiotics come from? Nat. Rev. Microbiol. 1, 65–70.

    Article  CAS  PubMed  Google Scholar 

  59. Labischinski, H., Ehlert, K., and Wieland, B. (1998) Novel anti-staphylococcal targets and compounds. Expert Opin. Invest. Drugs 7, 1245–1256.

    Article  CAS  Google Scholar 

  60. Shlaes, D. (2003) The abandonment of antibacterials: why and wherefore? Curr. Opin. Pharmacol. 3, 470–473.

    Article  CAS  PubMed  Google Scholar 

  61. Long, T. E. (2003) Recent progress towards the clinical development of new anti-MRSA antibiotics. IDrugs 6, 351–359.

    CAS  PubMed  Google Scholar 

  62. Khare, M. and Keady, D. (2003) Antimicrobial therapy of methicillin-resistant Staphylococcus aureus infections. Expert Opin. Pharmacother. 4, 165–177.

    Article  CAS  PubMed  Google Scholar 

  63. Wagenlehner, F. M. E. and Naber, K. G. (2004) New drugs for Gram-positive uropathogens. Int. J. Antimicrob. Agents 24S, S39–S43.

    Article  Google Scholar 

  64. Abbanat, D., Macielag, M., and Bush, K. (2003) Novel antibacterial agents for the treatment of serious Gram-positive infections. Expert Opin. Invest. Drugs 12, 379–399.

    Article  CAS  Google Scholar 

  65. Shinefield, H., Black, S., Fattom, A., et al. (2002) Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis. N. Engl. J. Med. 346, 491–496.

    Article  PubMed  Google Scholar 

  66. Welch, P. G., Fattom, A., Moore, J. Jr., et al. (1996) Safety and immunogenicity of Staphylococcus aureus type 5 capsular polysaccharide-Pseudomonas aeruginosa recombinant exoprotein A conjugate vaccine in patients on hemodialysis. J. Am. Soc. Nephrol. 7, 247–253.

    CAS  PubMed  Google Scholar 

  67. Fattom, A., Fuller, S., Propst, M., et al. (2004) Safety and immunogenicity of a booster dose of Staphylococcus aureus types 5 and 8 capsular polysaccharide conjugate vaccine (StaphVAX) in hemodialysis patients. Vaccine 16, 656–663.

    Article  Google Scholar 

  68. Cooper, B. S., Stone, S. P., Kibbler, C. C., et al. (2003) Systematic review of isolation policies in the hospital management of methicillin-resistant Staphylococcus aureus: a review of the literature with epidemiological and economic modelling. Health Technol. Assess. 7, 1–194.

    CAS  PubMed  Google Scholar 

  69. Bhalla, A., Pultz, N. J., Gries, D. M., et al. (2004) Acquisition of nosocomial pathogens on hands after contact with environmental surfaces near hospitalized patients. Infect. Control Hosp. Epidemiol. 25, 164–167.

    Article  PubMed  Google Scholar 

  70. Rice, L. B. (2003) Controlling antibiotic resistance in the ICU: different bacteria, different strategies. Cleveland Clinic J. Med. 70, 793–800.

    Article  Google Scholar 

  71. Kampf, G. (2003) State-of-the-art hand hygiene in community medicine. Int. J. Hyg. Environ. Health 206, 465–472.

    Article  PubMed  Google Scholar 

  72. Pujol, M., Pena, C., Pallares, R., et al. (1996) Nosocomial Staphylococcus aureus bacteremia among nasal carriers of methicillin-resistant and methicillin-susceptible strains. Am. J. Med. 100, 509–516.

    Article  CAS  PubMed  Google Scholar 

  73. Pittet, D., Mourougam, P., and Perneger, T. V. (1999) Compliance with handwashing in a teaching hospital. Infection Control Program. Ann. Intern. Med. 130, 126–130.

    CAS  PubMed  Google Scholar 

  74. Dirschka, T., Winter, K., Kralj, N., and Hofmann, F. (2004) Glove perforation in outpatient dermatologic surgery. Dermatol. Surg. 30, 1210–1213.

    Article  PubMed  Google Scholar 

  75. Yangco, B. G. and Yangco, N. F. (1989) What is leaky can be risky: a study of the integrity of hospital gloves. Infect. Control Hosp. Epidemiol. 10, 553–556.

    Article  CAS  PubMed  Google Scholar 

  76. Pittet, D., Dharan, S., Touveneau, S., Sauvan, V., and Perneger, T. V. (1999) Bacterial contamination of the hands of hospital staff during routine care. Arch. Intern. Med. 159, 821–826.

    Article  CAS  PubMed  Google Scholar 

  77. Pittet, D. and Boyce, J. M. (2003) Revolutionising hand hygiene in health-care settings: guidelines revisited. Lancet Infect. Dis. 3, 269, 270.

    Article  PubMed  Google Scholar 

  78. Kramer, A., Bernig, T., and Kampf, G. (2002) Clinical double-blind trial on the dermal tolerance and user acceptability of six alcohol-based hand disinfectants for hygienic hand disinfection. J. Hosp. Infect. 51, 114–120.

    Article  CAS  PubMed  Google Scholar 

  79. Blythe, D., Keenlyside, D., Dawson, S. J., and Galloway, A. (1998) Environmental contamination due to methicillin-resistant Staphylococcus aureus (MRSA). J. Hosp. Infect. 38, 67–69.

    Article  CAS  PubMed  Google Scholar 

  80. Donskey, C. J. (2004) The role of the intestinal tract as a reservoir and source for transmission of nosocomial pathogens. Clin. Infect. Dis. 39, 219–226; Epub 2004 Jun 25.

    Article  PubMed  Google Scholar 

  81. Monnet, D. L. (1998) Methicillin-resistant Staphylococcus aureus and its relationship to antimicrobial use: possible implications for control. Infect. Control Hosp. Epidemiol. 19, 552–559.

    Article  CAS  PubMed  Google Scholar 

  82. Johnson, A. P. (2003) Antibiotic resistance in the intensive care unit setting. Expert Rev. Anti. Infect. Ther. 1, 253–260.

    Article  PubMed  Google Scholar 

  83. Lowry, F. D. (2003) Antimicrobial resistance: the example of Staphylococcus aureus. J. Clin. Invest. 111, 1265–1273.

    Google Scholar 

  84. Kampf, G., Lecke, C., Cimbal, A. K., Weist, K., and Ruden, H. (1999) Evaluation of the BBL Crystal MRSA ID System for detection of oxacillin resistance in Staphylococcus aureus. J. Clin. Pathol. 52, 225–227.

    Article  CAS  PubMed  Google Scholar 

  85. Arbique, J., Forward, K., Haldane, D., and Davidson, R. (2001) Comparison of the Velogene Rapid MRSA Identification Assay, Denka MRSA-Screen Assay, and BBL Crystal MRSA ID System for rapid identification of methicillin-resistant Staphylococcus aureus. Diagn. Microbiol. Infect. Dis. 40, 5–10.

    Article  CAS  PubMed  Google Scholar 

  86. Louie, L., Matsumura, S. O., Choi, E., Louie, M., and Simor, A. E. (2000) Evaluation of three rapid methods for detection of methicillin resistance in Staphylococcus aureus. J. Clin. Microbiol. 38, 2170–2173.

    CAS  PubMed  Google Scholar 

  87. Levi, K. and Towner, K. J. (2003) Detection of methicillin-resistant Staphylococcus aureus (MRSA) in blood with the EVIGENE MRSA detection kit. J. Clin. Microbiol. 41, 3890–3892.

    Article  CAS  PubMed  Google Scholar 

  88. Maira-Litran, T., Kropec, A., Goldmann, D., and Pier, G. B. (2004) Biologic properties and vaccine potential of the staphylococcal poly-N-acetyl glucosamine surface polysaccharide. Vaccine 22, 872–879.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Infectious Disease Research, Merck & Co., Inc., Rahway, NJ

    Liangsu Wang PhD & John F. Barrett PhD

Authors
  1. Liangsu Wang PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John F. Barrett PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Veterinary and Biomedical Sciences, University of Minnesota, St. Paul, MN

    Yinduo Ji

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Humana Press Inc., Totowa, NJ

About this protocol

Cite this protocol

Wang, L., Barrett, J.F. (2007). Control and Prevention of MRSA Infections. In: Ji, Y. (eds) Methicillin-Resistant Staphylococcus aureus (MRSA) Protocols. Methods in Molecular Biology, vol 391. Humana Press. https://doi.org/10.1007/978-1-59745-468-1_16

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-468-1_16

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-655-9

  • Online ISBN: 978-1-59745-468-1

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation